Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

PubMed Links for Books (Select 2829014)

1.

Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance.

Van Onselen C, Cooper BA, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Paul S, Miaskowski C.

Support Care Cancer. 2012 Oct;20(10):2611-9.

PMID:
22290719
2.

The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.

Murillo-Rodriguez E, Poot-Ake A, Arias-Carrion O, Pacheco-Pantoja E, Fuente-Ortegon Ade L, Arankowsky-Sandoval G.

Cent Nerv Syst Agents Med Chem. 2011 Sep 1;11(3):189-96. Review.

PMID:
21919868
3.

Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes.

Jim HS, Small B, Faul LA, Franzen J, Apte S, Jacobsen PB.

Ann Behav Med. 2011 Dec;42(3):321-33. doi: 10.1007/s12160-011-9294-9.

4.

Sleep disturbance in hospitalized recipients of stem cell transplantation.

Boonstra L, Harden K, Jarvis S, Palmer S, Kavanaugh-Carveth P, Barnett J, Friese C.

Clin J Oncol Nurs. 2011 Jun;15(3):271-6. doi: 10.1188/11.CJON.271-276.

PMID:
21624862
5.

Changes in self-reported hot flashes and their association with concurrent changes in insomnia symptoms among women with breast cancer.

Savard MH, Savard J, Trudel-Fitzgerald C, Ivers H, Quesnel C.

Menopause. 2011 Sep;18(9):985-93. doi: 10.1097/gme.0b013e31820db6a1.

PMID:
21552166
6.

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.

Robson P.

Expert Opin Drug Saf. 2011 Sep;10(5):675-85. doi: 10.1517/14740338.2011.575778. Epub 2011 May 4. Review.

PMID:
21542664
7.
8.

The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

van Geijlswijk IM, Korzilius HP, Smits MG.

Sleep. 2010 Dec;33(12):1605-14. Review.

9.

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG.

J Psychopharmacol. 2010 Nov;24(11):1577-601. doi: 10.1177/0269881110379307. Epub 2010 Sep 2. Review.

PMID:
20813762
10.

Insomnia pharmacology.

Sullivan SS.

Med Clin North Am. 2010 May;94(3):563-80. doi: 10.1016/j.mcna.2010.02.012. Review.

PMID:
20451033
11.

Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors.

Otte JL, Carpenter JS, Russell KM, Bigatti S, Champion VL.

J Pain Symptom Manage. 2010 Mar;39(3):535-47. doi: 10.1016/j.jpainsymman.2009.07.004. Epub 2010 Jan 18.

12.

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.

Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR.

J Clin Oncol. 2010 Jan 10;28(2):292-8. doi: 10.1200/JCO.2009.22.5011. Epub 2009 Nov 23.

13.

Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.

Hrushesky WJ, Grutsch J, Wood P, Yang X, Oh EY, Ansell C, Kidder S, Ferrans C, Quiton DF, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D.

Integr Cancer Ther. 2009 Dec;8(4):387-97. doi: 10.1177/1534735409352086. Epub 2009 Nov 18. Review.

PMID:
19926611
14.

One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue.

Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, Agrawal S.

J Clin Oncol. 2009 Dec 10;27(35):6033-40. doi: 10.1200/JCO.2008.20.8306. Epub 2009 Nov 2.

15.

Update on the state of the science: sleep-wake disturbances in adult patients with cancer.

Berger AM.

Oncol Nurs Forum. 2009 Jul;36(4):E165-77. doi: 10.1188/09.ONF.E165-E177. Review.

PMID:
19581220
16.

Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue.

Berger AM, Kuhn BR, Farr LA, Lynch JC, Agrawal S, Chamberlain J, Von Essen SG.

Psychooncology. 2009 Jun;18(6):634-46. doi: 10.1002/pon.1438.

PMID:
19090531
17.

Melatonin as a biomarker of circadian dysregulation.

Mirick DK, Davis S.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3306-13. doi: 10.1158/1055-9965.EPI-08-0605. Review.

18.

Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer.

Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J.

J Clin Oncol. 2008 Oct 1;26(28):4651-8. doi: 10.1200/JCO.2007.13.9006. Epub 2008 Jun 30. Erratum in: J Clin Oncol. 2010 Jul 1;28(19):3205.

19.

Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.

Payne JK, Held J, Thorpe J, Shaw H.

Oncol Nurs Forum. 2008 Jul;35(4):635-42. doi: 10.1188/08.ONF.635-642.

PMID:
18591167
20.

Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana.

Schierenbeck T, Riemann D, Berger M, Hornyak M.

Sleep Med Rev. 2008 Oct;12(5):381-9. doi: 10.1016/j.smrv.2007.12.004. Epub 2008 Mar 3. Review.

PMID:
18313952
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk